Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT04987307 · TERMINATED

Trial details

NCT number: NCT04987307
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2022-01-31
Primary completion: 2024-10-22
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.